Search Results | Cancer Prevention Research | American Association for Cancer Research

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy

Meghna S. Trivedi, Nadir Arber, Eitan Friedman, Judy E. Garber, Kevin Holcomb, Neil S. Horowitz, Jason D. Wright, J. Jack Lee, Lana A. Vornik, Saba Abutaseh, Tawana Castile, Edward R. Sauter, Eileen Dimond, Brandy M. Heckman-Stoddard, Margaret House, Goli Samimi, Powel H. Brown, Katherine D. Crew

Cancer Prev Res (Phila) (2022) 15 (11): 721–726.

DOI: https://doi.org/10.1158/1940-6207.CAPR-22-0051

Published: 01 November 2022

View article titled, Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy

Journal Articles

Patient and Provider Web-Based Decision Support for Breast Cancer Chemoprevention: A Randomized Controlled Trial

Katherine D. Crew, Gauri Bhatkhande, Thomas Silverman, Jacquelyn Amenta, Tarsha Jones, Julia E. McGuinness, Jennie Mata, Ashlee Guzman, Ting He, Jill Dimond, Wei-Yann Tsai, Rita Kukafka

Cancer Prev Res (Phila) (2022) 15 (10): 689–700.

DOI: https://doi.org/10.1158/1940-6207.CAPR-22-0013

Published: 04 October 2022

View article titled, Patient and Provider Web-Based Decision Support for Breast Cancer Chemoprevention: A Randomized Controlled Trial

Journal Articles

Strategies to Identify and Recruit Women at High Risk for Breast Cancer to a Randomized Controlled Trial of Web-based Decision Support Tools

Julia E. McGuinness, Gauri Bhatkhande, Jacquelyn Amenta, Thomas Silverman, Jennie Mata, Ashlee Guzman, Ting He, Jill Dimond, Tarsha Jones, Rita Kukafka, Katherine D. Crew

Cancer Prev Res (Phila) (2022) 15 (6): 399–406.

DOI: https://doi.org/10.1158/1940-6207.CAPR-21-0593

Published: 02 June 2022

View article titled, Strategies to Identify and Recruit Women at High Risk for Breast Cancer to a Randomized Controlled Trial of Web-based Decision Support Tools

Journal Articles

Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812)

Cancer Prev Res (Phila) (2019) 12 (7): 481–490.

DOI: https://doi.org/10.1158/1940-6207.CAPR-18-0444

Published: 03 July 2019

View article titled, Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812)

Includes: Supplementary data

Journal Articles

A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease

Cancer Prev Res (Phila) (2018) 11 (4): 203–214.

DOI: https://doi.org/10.1158/1940-6207.CAPR-17-0354

Published: 01 April 2018

View article titled, A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease

Includes: Supplementary data

Journal Articles

What Factors Influence Decision-Making about Breast Cancer Chemoprevention among High-Risk Women?

Katherine D. Crew

Cancer Prev Res (Phila) (2017) 10 (11): 609–611.

DOI: https://doi.org/10.1158/1940-6207.CAPR-17-0281

Published: 31 October 2017

View article titled, What Factors Influence Decision-Making about Breast Cancer Chemoprevention among High-Risk Women?

Journal Articles

Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma In Situ

Meghna S. Trivedi, Austin M. Coe, Alejandro Vanegas, Rita Kukafka, Katherine D. Crew

Cancer Prev Res (Phila) (2017) 10 (8): 434–441.

DOI: https://doi.org/10.1158/1940-6207.CAPR-17-0100

Published: 01 August 2017

View article titled, Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma In Situ

Journal Articles

Abstract PR01: Knowledge, attitudes, and uptake of breast cancer chemoprevention in a multi-ethnic cohort of high-risk women

Meghna S. Trivedi, Laura Reimers, Katherine Infante, Dawn L. Hershman, Matthew Maurer, Kevin Kalinsky, Stephanie Aguilar, Rossy Sandoval, Maria C. Alvarez, Rita Kukafka, Katherine D. Crew

Cancer Prev Res (Phila) (2015) 8 (10_Supplement): PR01.

DOI: https://doi.org/10.1158/1940-6215.PREV-14-PR01

Published: 02 October 2015

View article titled, Abstract PR01: Knowledge, attitudes, and uptake of breast cancer chemoprevention in a multi-ethnic cohort of high-risk women

Journal Articles

Abstract A48: Pitfalls of using breast magnetic resonance imaging (MRI) in an early-phase breast cancer chemoprevention trial of vitamin D among high-risk postmenopausal women

Laura L. Reimers, Dawn L. Hershman, Matthew Maurer, Kevin Kalinsky, Lois Brafman, Grace Kranwinkel, Katherine D. Crew

Cancer Prev Res (Phila) (2011) 4 (10_Supplement): A48.

DOI: https://doi.org/10.1158/1940-6207.PREV-11-A48

Published: 23 October 2014

View article titled, Abstract A48: Pitfalls of using breast magnetic resonance imaging (MRI) in an early-phase breast cancer chemoprevention trial of vitamin D among high-risk postmenopausal women

Journal Articles

Abstract CN06-02: Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of Polyphenon E in women with a history of hormone receptor-negative breast cancer

Katherine D. Crew, Scott Lippman, Dawn L. Hershman, Powel Brown, Heather Greenlee, Therese Bevers, Banu Arun, Clifford Hudis, Heather McArthur, Lana Vornik, Terri Cornelison

Cancer Prev Res (Phila) (2011) 4 (10_Supplement): CN06-02.

DOI: https://doi.org/10.1158/1940-6207.PREV-11-CN06-02

Published: 23 October 2014

View article titled, Abstract CN06-02: Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of Polyphenon E in women with a history of hormone receptor-negative breast cancer

Journal Articles

Abstract C03: Development of a patient-centered decision aid to improve accuracy of breast cancer risk perception

Tong Xiao, Katherine D. Crew, Parijatham S. Sivasubramanian, Alejandra N. Aguirre, Cindy K. Smalletz, Rita Kukafka

Cancer Prev Res (Phila) (2013) 6 (11_Supplement): C03.

DOI: https://doi.org/10.1158/1940-6215.PREV-13-C03

Published: 28 August 2014

View article titled, Abstract C03: Development of a patient-centered decision aid to improve accuracy of breast cancer risk perception

Journal Articles

Abstract C28: Effects of vitamin D supplementation on breast imaging and blood-based biomarkers of breast cancer risk

Parijatham S. Sivasubramanian, Tong Xiao, Dawn L. Hershman, Matthew Maurer, Kevin Kalinsky, Sheldon Feldman, Sr., Lois Brafman, Susan Refice, Grace Kranwinkel, Katherine D. Crew

Cancer Prev Res (Phila) (2013) 6 (11_Supplement): C28.

DOI: https://doi.org/10.1158/1940-6215.PREV-13-C28

Published: 28 August 2014

View article titled, Abstract C28: Effects of vitamin D supplementation on breast imaging and blood-based biomarkers of breast cancer risk

Journal Articles

Abstract A73: Evaluating tissue biomarker effects of an oral green tea extract, polyphenon E, using reverse phase protein array in women with operable breast cancer

Kimberly A. Ho, Davida Kornreich, James A. Cardelli, Jerry McLarty, Dawn L. Hershman, Matthew Maurer, Kevin Kalinsky, Bret Taback, Hanina Hibshoosh, Tao Su, Susan F. Refice, Katherine D. Crew

Cancer Prev Res (Phila) (2012) 5 (11_Supplement): A73.

DOI: https://doi.org/10.1158/1940-6207.PREV-12-A73

Published: 23 January 2014

View article titled, Abstract A73: Evaluating tissue biomarker effects of an oral green tea extract, polyphenon E, using reverse phase protein array in women with operable breast cancer

Journal Articles

Abstract B65: Biomarker effects of an oral green tea extract, Polyphenon E, in women with a history of hormone receptor-negative breast cancer

Katherine D. Crew, Kimberly A. Ho, Powel Brown, Heather Greenlee, Therese B. Bevers, Banu Arun, Clifford Hudis, Heather L. McArthur, Jenny Chang, Mothaffar Rimawi, Lana Vornik, Terri L. Cornelison, James Cardelli, Regina M. Santella, Antai Wang, Scott M. Lippman, Dawn L. Hershman

Cancer Prev Res (Phila) (2012) 5 (11_Supplement): B65.

DOI: https://doi.org/10.1158/1940-6207.PREV-12-B65

Published: 23 January 2014

View article titled, Abstract B65: Biomarker effects of an oral green tea extract, Polyphenon E, in women with a history of hormone receptor-negative breast cancer

Journal Articles

Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer

Katherine D. Crew, Powel Brown, Heather Greenlee, Therese B. Bevers, Banu Arun, Clifford Hudis, Heather L. McArthur, Jenny Chang, Mothaffar Rimawi, Lana Vornik, Terri L. Cornelison, Antai Wang, Hanina Hibshoosh, Aqeel Ahmed, Mary Beth Terry, Regina M. Santella, Scott M. Lippman, Dawn L. Hershman

Cancer Prev Res (Phila) (2012) 5 (9): 1144–1154.

DOI: https://doi.org/10.1158/1940-6207.CAPR-12-0117

Published: 04 September 2012

View article titled, Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer

Includes: Supplementary data

Journal Articles

Association between Plasma 25-Hydroxyvitamin D and Breast Cancer Risk

Katherine D. Crew, Marilie D. Gammon, Susan E. Steck, Dawn L. Hershman, Serge Cremers, Elzbieta Dworakowski, Elizabeth Shane, Mary Beth Terry, Manisha Desai, Susan L. Teitelbaum, Alfred I. Neugut, Regina M. Santella

Cancer Prev Res (Phila) (2009) 2 (6): 598–604.

DOI: https://doi.org/10.1158/1940-6207.CAPR-08-0138

Published: 04 June 2009

View article titled, Association between Plasma 25-Hydroxyvitamin D and Breast Cancer Risk

NARROW

Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy

Patient and Provider Web-Based Decision Support for Breast Cancer Chemoprevention: A Randomized Controlled Trial

Strategies to Identify and Recruit Women at High Risk for Breast Cancer to a Randomized Controlled Trial of Web-based Decision Support Tools

Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812)

A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease

What Factors Influence Decision-Making about Breast Cancer Chemoprevention among High-Risk Women?

Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma In Situ

Abstract PR01: Knowledge, attitudes, and uptake of breast cancer chemoprevention in a multi-ethnic cohort of high-risk women

Abstract A48: Pitfalls of using breast magnetic resonance imaging (MRI) in an early-phase breast cancer chemoprevention trial of vitamin D among high-risk postmenopausal women

Abstract CN06-02: Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of Polyphenon E in women with a history of hormone receptor-negative breast cancer

Abstract C03: Development of a patient-centered decision aid to improve accuracy of breast cancer risk perception

Abstract C28: Effects of vitamin D supplementation on breast imaging and blood-based biomarkers of breast cancer risk

Abstract A73: Evaluating tissue biomarker effects of an oral green tea extract, polyphenon E, using reverse phase protein array in women with operable breast cancer

Abstract B65: Biomarker effects of an oral green tea extract, Polyphenon E, in women with a history of hormone receptor-negative breast cancer

Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer

Association between Plasma 25-Hydroxyvitamin D and Breast Cancer Risk

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only